home *** CD-ROM | disk | FTP | other *** search
- From: jkenner@cello.gina.calstate.edu (Jason Kennerly)
- Newsgroups: alt.drugs.chemistry,alt.psychoactives,sci.med.psychobiology,bionet.neuroscience,alt.bio.hackers
- Subject: N substituted xanthines
- Date: 22 Sep 1995 13:18:51 -0700
- Message-ID: <43v5nb$mic@cello.gina.calstate.edu>
-
- Here is the information I have gathered so far on caffeine analogs, with
- abstracts as references. Any other information on any of these compounds,
- or other n-substituted xanthines would be of great interest to me,
- especially concerning the use of such compounds in humans ["tasting"]
-
- N-SUBSTITUTED XANTHINES:
- a CAFFEINE ANALOG information file.
-
-
- ASCII DEPICTIONS, SUMMARY INFO
- ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~
- chart:
- A1: Activity at A1 reletive to caffeine
- A2: Activity at A2 reletive to caffeine
- PDE: PDE inhibiton reletive to caffeine
- Action: Depressant or Stimulant of behaviour
-
-
- O CH3 O
- || | || H
- H3C C N{7} H3C C N
- \ / \ / \ \ / \ / \
- {1}N || \ N || \
- | || // | || //
- //\ / \// //\ / \//
- O N{3} N O N N
- | |
- CH3 CH3
-
- Caffeine Theophylline
- A1: 1 A1: ?
- A2: 1 A2: ?
- PDE: is PDE: ?(less?)
- Action: Stimulant Action: weak Stimulant
-
-
-
-
- -----------------------------------------------------------------------
-
- CH
- |||
- CH H2C--C
- ||| |
- C O CH3 O CH2
- | || | || |
- H2C C N H3C C N
- \ / \ / \ \ / \ / \
- N || \ N || \
- | || // | || //
- //\ / \// //\ / \//
- O N N O N N
- | |
- CH3 CH3
-
- 1-Proparagyl 3,7-Dimethyl 7-Proparagyl 1,3-Dimethyl
- Xanthine Xanthine
- A1: .5 A1: .5
- A2: 4 to 7 A2: 3 to 4
- PDE: less PDE: ?
- Action: Stimulant Action: ?
- -----------------------------------------------------------------------
-
- CH CH
- ||| |||
- O CH3 C O H2C--C
- || | | || |
- H3C C N H2C C N
- \ / \ / \ \ / \ / \
- N || \ N || \
- | || // | || //
- //\ / \// //\ / \//
- O N N O N N
- | |
- C--CH2 C--CH2
- ||| |||
- CH CH
-
- 3-Proparagyl 1,7-Dimethyl 1,3,7-Triproparagyl
- Xanthine Xanthine
- A1: ? high in A1: ? high in
- A2: ? general A2: ? general
- PDE: less PDE: less
- Action: Stimulant Action: Stimulant
-
- -----------------------------------------------------------------------
-
- O O CH2-CH2-CH3
- || H || |
- H3C C N H3C-H2C-H2C C N
- \ / \ / \ \ / \ / \
- N || \ N || \
- | || // | || //
- //\ / \// //\ / \//
- O N N O N N
- | |
- C CH2-CH2-CH2
- / \
- H3C CH2-CH3
-
- IBMX 1,3,7-Tripropyl Xanthine
- A1: ? A1: higher than 1,3,7 triproparagyl-x!
- A2: ? A2: higher ""
- PDE: high PDE: higher ""
- Action: Depressant Action: Depressant [due to PDE]
-
- -----------------------------------------------------------------------
- _____
- / _ \
- O CH2-< (_) > O CH3
- || | \_____/ || |
- H3C C N H3C-H2C-H2C C N
- \ / \ / \ \ / \ / \
- N || \ N || \
- | || // | || //
- //\ / \// //\ / \//
- O N N O N N
- | |
- C CH3
- / \
- H3C CH2-CH3
-
- 7-Benzyl-IBMX 1-Propyl 3,7-Dimethyl Xanthine
- A1: ? (high) A1: 1.4
- A2: ? (high) A2: >10
- PDE: ? (high) PDE: ?
- Action: weak Stimulant Action: ?
-
- -----------------------------------------------------------------------
-
- CH
- |||
- O CH3 O H2C--C
- || | || |
- H3C-H2C-H2C C N H3C-H2C-H2C C N
- \ / \ / \ \ / \ / \
- N || \ N || \
- | || // | || //
- //\ / \// //\ / \//
- O N N O N N
- | |
- CH2-CH2-CH3 CH2-CH2-CH3
-
- 1,3-Dipropyl 7-Methyl 1,3-Dipropyl 7-Proparagyl
- Xanthine Xanthine
- A1: 8 A1: ~100
- A2: 40 A2: ~100
- PDE: ? PDE: ?
- Action: ? Action: ?
-
- -----------------------------------------------------------------------
-
- O CH3 O H2C--CH==CH2
- || | || |
- H3C C N H3C C N
- \ / \ / \ \ / \ / \
- N || \ N || \
- | || // | || //
- //\ / \// //\ / \//
- O N N O N N
- | |
- CH3 CH3
-
- 3,7-Dimethyl 1-Propyl 7-allyl 1,3-dimethyl
- Xanthine Xanthine
- A1: ? A1: ?
- A2: more than A1 A2: more than A1
- PDE: ? PDE: ?
- Action: ? Action: ?
-
- ***Abstracts of articles where above information was obtained***
-
- CAFFEINE ANALOGS: STRUCTURE-ACTIVITY RELATIONSHIPS AT ADENOSINE RECEPTORS.
- Daly JW; Hide I; Muller CE; Shamim M
- Laboratory of Bioorganic Chemistry, National Institute of Diabetes,
- Digestive and Kidney Diseases, National Institutes of Health,
- Bethesda, Md.
- Pharmacology 42: 309-21 (1991)
-
- Abstract
- Caffeine and analogs that contain ethyl, propyl, allyl, propargyl and
- other substituents in place of methyl at 1-, 3- and 7-positions were
- antagonists at the two major classes (A1 and A2) of adenosine
- receptors. Potency at both receptors increased as methyls were
- replaced with larger substituents. Certain analogs with only one of
- the three methyl groups of caffeine replaced by larger substituents
- were somewhat selective for A2 receptors. None of the analogs were
- particularly selective for A1 receptors. The presence of polar
- entities in the substituent at the 1- or 7-position was poorly
- tolerated at adenosine receptors. Activity of caffeine analogs at A1
- and A2 adenosine receptors in a variety of systems and cell types is
- presented and summarized.
-
- ***
-
- ANALOGS OF CAFFEINE: ANTAGONISTS WITH SELECTIVITY FOR A2 ADENOSINE RECEPTORS.
- Ukena D; Shamim MT; Padgett W; Daly JW
- Life Sci 39: 743-50 (1986)
-
- Abstract
- Several analogs of caffeine have been investigated as antagonists at
- A2 adenosine receptors stimulatory to adenylate cyclase in membranes
- from rat pheochromocytoma PC12 cells and human platelets and at A1
- adenosine receptors inhibitory to adenylate cyclase from rat fat
- cells. Among these analogs, 1-propargyl-3,7-dimethylxanthine was about
- 4- to 7-fold and 7-propyl-1,3-dimethylxanthine about 3- to 4-fold more
- potent than caffeine at A2 receptors of PC12 cells and platelets. At
- A1 receptors of fat cells, both compounds were about 2-fold less
- potent than caffeine. These caffeine analogs have an A1/A2 selectivity
- ratio of about 10-20 and are the first selective A2 receptor
- antagonists yet reported. The results may provide the basis for the
- further development of highly potent and highly selective A2 adenosine
- receptor antagonists.
-
- ***
-
- CAFFEINE AND THEOPHYLLINE ANALOGUES: CORRELATION OF BEHAVIORAL EFFECTS WITH
- ACTIVITY AS ADENOSINE RECEPTOR ANTAGONISTS AND AS PHOSPHODIESTERASE INHIBITORS.
- Choi OH; Shamim MT; Padgett WL; Daly JW
- Laboratory of Bioorganic Chemistry, National Institute of Diabetes,
- Digestive and Kidney Diseases, Bethesda, Maryland 20892.
- Life Sci 43: 387-98 (1988)
-
- Abstract
- The behavioral stimulant effects of xanthines, such as caffeine and
- theophylline, appear to involve blockade of central adenosine
- receptors. However, 3-isobutyl-1-methylxanthine (IBMX), a potent
- phosphodiesterase (PDE) inhibitor, produces behavioral depression. The
- effects of caffeine analogs on open field behavior of mice and
- potencies as antagonists of adenosine receptors and as inhibitors of
- three classes of brain PDE have been compared.
- 1,7-Dimethyl-3-propargylxanthine, 1,3,7-tripropargylxanthine, and
- 3,7-dimethyl-1-propargylxanthine, which have high affinity for
- adenosine receptors and weaker activity as PDE inhibitors, all
- increase behavioral activity. In contrast, 1,3,7-tripropylxanthine, a
- more potent inhibitor of the brain calcium-independent (Ca-indep) PDEs
- than 1,3,7-tripropargylxanthine, produces behavioral depression, even
- though both analogues are potent adenosine receptor antagonists.
- 7-Benzyl-IBMX, an active receptor antagonist and selective inhibitor
- of a brain calcium-dependent (Ca-dep) PDE, produces a slight
- behavioral activation. Xanthines that are potent adenosine receptor
- antagonists and relatively weak inhibitors of the Ca-indep PDEs
- reverse the depressant effects of N6-cyclohexyladenosine, while
- xanthines, such as 1,3,7-tripropylxanthine, that are potent inhibitors
- of the Ca-indep PDEs, do not. The results suggest that the behavioral
- effects of xanthines may be determined primarily by relative activity
- as adenosine receptor antagonists and as inhibitors of brain Ca-indep
- PDEs.
-
- ***
-
- ANALOGUES OF CAFFEINE AND THEOPHYLLINE: EFFECT OF STRUCTURAL ALTERATIONS ON
- AFFINITY AT ADENOSINE RECEPTORS.
- Daly JW; Padgett WL; Shamim MT
- J Med Chem 29: 1305-8 (1986)
-
- Abstract
- A variety of analogues of caffeine and theophylline in which the
- 1-,3-, and 7-methyl substituents have been replaced with n-propyl,
- allyl, propargyl, and isobutyl and, in a few cases, with chloroethyl,
- hydroxyethyl, or benzyl were assessed for potency and selectivity as
- antagonists at A1- and A2-adenosine receptors in brain tissue.
- Caffeine and theophylline are nonselective for these receptors. Nearly
- all of the 22 analogues of caffeine are more potent than caffeine
- itself at adenosine receptors. Replacement of the 1-methyl moiety with
- n-propyl, allyl, or propargyl substituent has little effect on potency
- at the A1 receptor while enhancing potency about 7- to 10-fold at the
- A2 receptor. 3,7-Di-methyl-1-propylxanthine is only slightly
- (1.4-fold) more potent than caffeine at the A1 receptor while being
- 10-fold more potent at the A2 receptor.
- 1,3-Di-n-propyl-7-methylxanthine is also selective for the A2
- receptor, being 8-fold more potent than caffeine at the A1 receptor
- and 40-fold more potent at the A2 receptor.
- A number of other caffeine analogues including
- 3,7-dimethyl-1-n-propylxanthine, 7-allyl-1,3-dimethylxanthine, and
- 1,3-dimethyl-7-propargylxanthine are also somewhat selective for the
- A2 receptor.
- The most potent caffeine analogue was 1,3-di-n-propyl-7-propargylxanthine,
- which was about 100-fold more potent than caffeine at both A1 and A2
- receptors.
- The 10 theophylline analogues were relatively nonselective except for the
- 1-ethyl analogue and the 1,3-diallyl analogue, which were selective
- for the A2 receptor, and the 1,3-di-n-propyl, 1,3-diisobutyl, and
- 1,3-dibenzyl analogues, which were somewhat selective for the A1
- receptor. 1,3-Di-n-propylxanthine was 20-fold more potent than
- theophylline at the A1 receptor and 5-fold more potent at the A2
- receptor.
-
- ***
-
- ADENOSINE RECEPTORS: DEVELOPMENT OF SELECTIVE AGONISTS AND ANTAGONISTS.
- Daly JW; Jacobson KA; Ukena D
- Prog Clin Biol Res 230: 41-63 (1987)
-
- Abstract
- Adenosine modulates a variety of physiological functions through
- interaction with A1 and A2 adenosine receptors, where agonists mediate
- inhibition and stimulation, respectively, of adenylate cyclase. In the
- cardiovascular system, A2 receptors mediate vasodilation and reduction
- in blood pressure, while A1 receptors mediate cardiac depression. The
- involvement of adenylate cyclase in these responses remains
- unresolved. Adenosine analogs in particular the N6-substituted
- compounds are more potent at A1 receptors than at A2 receptors. The
- subregion of the adenosine receptor that interacts with the
- N6-substituent is different for A1 and A2 receptors, particularly with
- respect to phenyl interactions, bulk tolerance and stereoselectivity.
- A series of para-substituted N6-phenyladenosines have been synthesized
- based on a "functionalized congener" approach in which a chemically
- reactive group, such as an amine or carboxylic acid, is introduced at
- the terminus of a chain. From the "functionalized congener" are
- synthesized a variety of conjugates each containing a common
- pharmacophore. Certain of the adenosine conjugates are highly
- selective for A1 receptors. Xanthines are classical antagonists for
- adenosine receptors for many of their pharmacological actions may be
- due to blockade of adenosine receptors. Caffeine and theophylline are
- virtually non-selective for A2 and A2 receptors. Replacement of the
- methyl groups of theophylline with n-propyl or larger alkyl groups
- yields xanthines with selectivity for A1 receptors, particularly when
- combined with an 8-phenyl moiety. Most 1,3-dialkyl-8-phenyl xanthines
- are very insoluble, but incorporation of polar aryl substituents, such
- as sulfo or carboxy to increase solubility, results in marked
- reduction in potency and selectivity. A new series of more hydrophilic
- 1,3-dipropyl-8-phenylxanthines has been synthesized using the
- "functionalized congener" approach. Certain conjugates of
- 8-[4-(carboxymethyloxy)phenyl 1]1,3-dipropylxanthine display A1
- selectivity in biochemical and cardiovascular models. Certain analogs
- of caffeine in which the methyl group at the 1- or 7-position is
- replaced with a propargyl or propyl group display selectivity for A2
- receptors. The profile of a series of adenosine analogs or of xanthine
- antagonists can be used to define the nature of adenosine receptors.
-
-
-
- --
- ____ ______ ________ _____
- / \ | \| /\ | \ jkenner@cello.gina.calstate.edu
- / \| _ \ \/ | _ \
- /___/\ \___|> > |__|> > BORN TO BE WIRED...
- / | / /\ | / All the sugar and twice the
- \_________|______/|___\/__|______/ caffeine of regular netusers!
- finger me and make a pgp key come.
-
-
-